1. Recent advances in the strategic incorporation of fluorine into new-generation taxoid anticancer agents
   Kalani Jayanetti et al, 2023, Journal of Fluorine Chemistry CrossRef
2. The Role of TRIP6, ABCC3 and CPS1 Expression in Resistance of Ovarian Cancer to Taxanes
   Karolina Seborova et al, 2021, International Journal of Molecular Sciences CrossRef
3. A novel taxane, difluorovinyl-ortataxel, effectively overcomes paclitaxel-resistance in breast cancer cells
   Dade Rong et al, 2020, Cancer Letters CrossRef
4. Transgelin-2, a novel cancer stem cell-related biomarker, is a diagnostic and therapeutic target for biliary tract cancer
   Jung Hyun Jo et al, 2024, BMC Cancer CrossRef
5. Microtubule-targeting agents and their impact on cancer treatment
   Vladimír Čermák et al, 2020, European Journal of Cell Biology CrossRef
6. Strategies for the drug discovery and development of taxane anticancer therapeutics
   Changwei Wang et al, 2022, Expert Opinion on Drug Discovery CrossRef
7. Hydrous icaritin nanorods with excellent stability improves the in vitro and in vivo activity against breast cancer
   Yian Wang et al, 2020, Drug Delivery CrossRef
8. Transgelin-2 is a novel target of KRAS-ERK signaling involved in the development of pancreatic cancer
   Yan Sun et al, 2018, Journal of Experimental & Clinical Cancer Research CrossRef
9. Recent progress in the strategic incorporation of fluorine into medicinally active compounds
   Krupanandan Haranahalli et al, 2019, Journal of Fluorine Chemistry CrossRef
10. Pharmaceutical applications of organofluorine compounds
    V. Prakash Reddy, 2020, Organofluorine Chemistry CrossRef
11. A new core–shell-type nanoparticle loaded with paclitaxel/norcantharidin and modified with APRPG enhances anti-tumor effects in hepatocellular carcinoma
    Ming-Hua Xie et al, 2022, Frontiers in Oncology CrossRef
12. Preparation of hydroxy genkwanin nanosuspensions and their enhanced antitumor efficacy against breast cancer
    Hui Ao et al, 2020, Drug Delivery CrossRef
13. Biocatalysis of precursors to new-generation SB-T-taxanes effective against paclitaxel-resistant cancer cells
    Aimen Al-Hilfi et al, 2022, Archives of Biochemistry and Biophysics CrossRef
14. Design, synthesis and SAR study of Fluorine-containing 3rd-generation taxoids
    Changwei Wang et al, 2022, Bioorganic Chemistry CrossRef
15. Quest for Efficacious Next-Generation Taxoid Anticancer Agents and Their Tumor-Targeted Delivery
    Iwao Ojima et al, 2018, Journal of Natural Products CrossRef
16. Design, synthesis and SAR study of 3rd-generation taxoids bearing 3-CH3, 3-CF3O and 3-CHF2O groups at the C2-benzoate position
    Changwei Wang et al, 2020, Bioorganic Chemistry CrossRef
17. Transgelin-2: Biochemical and Clinical Implications in Cancer and Asthma
    Lei-Miao Yin et al, 2019, Trends in Biochemical Sciences CrossRef
18. Microtubule Targeting Agents in Disease: Classic Drugs, Novel Roles
    Linda Wordeman et al, 2021, Cancers CrossRef
19. Detection of phenotype‐specific therapeutic vulnerabilities in breast cells using a CRISPR loss‐of‐function screen
    Anna Barkovskaya et al, 2021, Molecular Oncology CrossRef